Startseite UR
Einträge von Blankenstein, Christiane auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 3.
Multhoff, Gabriele, Seier, Sophie, Stangl, Stefan, Sievert, Wolfgang, Shevtsov, Maxim 
, Werner, Caroline, Pockley, A. Graham , Blankenstein, Christiane, Hildebrandt, Martin, Offner, Robert, Ahrens, Norbert, Kokowski, Konrad, Hautmann, Matthias, Rödel, Claus, Fietkau, Rainer, Lubgan, Dorota, Huber, Rudolf , Hautmann, Hubert, Duell, Thomas, Molls, Michael, Specht, Hanno, Haller, Bernhard, Devecka, Michal, Sauter, Andreas und Combs, Stephanie E.
(2020)
Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
Clinical Cancer Research 26 (20), S. 5368-5379.
Volltext nicht vorhanden.
, Werner, Caroline, Pockley, A. Graham , Blankenstein, Christiane, Hildebrandt, Martin, Offner, Robert, Ahrens, Norbert, Kokowski, Konrad, Hautmann, Matthias, Rödel, Claus, Fietkau, Rainer, Lubgan, Dorota, Huber, Rudolf , Hautmann, Hubert, Duell, Thomas, Molls, Michael, Specht, Hanno, Haller, Bernhard, Devecka, Michal, Sauter, Andreas und Combs, Stephanie E.
(2020)
Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
Clinical Cancer Research 26 (20), S. 5368-5379.
Volltext nicht vorhanden.
Multhoff, Gabriele, Combs, Stephanie E., Seier, Sophie, Stangl, Stefan, Sievert, Wolfgang, Shevtsov, Maxim , Blankenstein, Christiane, Hildebrandt, Martin, Kokowski, Konrad, Hautmann, Matthias, Hautmann, Hubert, Rödel, Claus, Fietkau, Rainer, Huber, Rudolf , Haller, Bernhard, Ertl, Christine, Devecka, Michal, Offner, Robert und Ahrens, Norbert
(2020)
Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30).
Cancer research 80 (16supp).
Volltext nicht vorhanden.
, Blankenstein, Christiane, Hildebrandt, Martin, Kokowski, Konrad, Hautmann, Matthias, Hautmann, Hubert, Rödel, Claus, Fietkau, Rainer, Huber, Rudolf , Haller, Bernhard, Ertl, Christine, Devecka, Michal, Offner, Robert und Ahrens, Norbert
(2020)
Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30).
Cancer research 80 (16supp).
Volltext nicht vorhanden.
Specht, Hanno M., Ahrens, Norbert , Blankenstein, Christiane, Duell, Thomas, Fietkau, Rainer, Gaipl, Udo S. , Günther, Christine, Gunther, Sophie, Habl, Gregor, Hautmann, Hubert, Hautmann, Matthias , Huber, Rudolf Maria, Molls, Michael, Offner, Robert , Rödel, Claus, Rödel, Franz, Schütz, Martin, Combs, Stephanie E. und Multhoff, Gabriele
(2015)
Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) – from preclinical studies to a clinical phase II trial.
Frontiers in immunology 6, S. 162.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707